Fructose, glucocorticoids and adipose tissue: Implications for the metabolic syndrome

Nutrients

Volumn 9, Issue 5, 2017, Pages

  Legeza, Balázs ^a,b   Marcolongo, Paola ^c   Gamberucci, Alessandra ^c   Varga, Viola ^b   Bánhegyi, Gábor ^b   Benedetti, Angiolo ^c   Odermatt, Alex ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Adipogenesis; Fructose; Glucocorticoid; Metabolic syndrome; Obesity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; FRUCTOSE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE TRANSPORTER 5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MINERALOCORTICOID RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; HSD11B1 PROTEIN, HUMAN;

ADIPOGENESIS; ADIPOSE TISSUE; DYSLIPIDEMIA; FOOD INTAKE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; SUGAR INTAKE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; FRUCTOSE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HUMANS; METABOLIC SYNDROME;

EID: 85018313995     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9050426     Document Type: Review

References (149)

1. Malik, V.S., Hu, F.B. Fructose and Cardiometabolic Health: What the Evidence from Sugar-Sweetened Beverages Tells Us. J. Am. Coll. Cardiol. 2015, 66, 1615-1624.
2. Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, M.K. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295, 1549-1555.
3. Malik, V.S., Popkin, B.M., Bray, G.A., Despres, J.P., Hu, F.B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121, 1356-1364.
4. Malik, V.S., Popkin, B.M., Bray, G.A., Despres, J.P., Willett, W.C., Hu, F.B. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: A meta-analysis. Diabetes Care 2010, 33, 2477-2483.
5. Yudkin, J., Roddy, J. Levels of Dietary Sucrose in Patients with Occlusive Atherosclerotic Disease. Lancet 1964, 2, 6-8.
6. Bantle, J.P., Laine, D.C., Thomas, J.W. Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA 1986, 256, 3241-3246.
7. Despres, J.P., Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 2006, 444, 881-887.
8. Cristancho, A.G., Lazar, M.A. Forming functional fat: A growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 2011, 12, 722-734.
9. Trayhurn, P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. 2013, 93, 1-21.
10. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 2006, 444, 860-867.
11. Calder, P.C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jonsson, L.S., Kolb, H., Lansink, M., et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 2011, 106 (Suppl 3), S5-S78.
12. Park, Y.K., Yetley, E.A. Intakes and food sources of fructose in the United States. Am. J. Clin. Nutr. 1993, 58 (Suppl 5), 737S-747S.
13. Vos, M.B., Kimmons, J.E., Gillespie, C., Welsh, J., Blanck, H.M. Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey. Medscape J. Med. 2008, 10, 160.
14. Bray, G.A., Nielsen, S.J., Popkin, B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 2004, 79, 537-543.
15. Stanhope, K.L., Havel, P.J. Fructose consumption: Potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr. Opin. Lipidol. 2008, 19, 16-24.
16. Tappy, L., Le, K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90, 23-46.
17. Bizeau, M.E., Pagliassotti, M.J. Hepatic adaptations to sucrose and fructose. Metabolism 2005, 54, 1189-1201.
18. Hanover, L.M., White, J.S. Manufacturing, composition, and applications of fructose. Am. J. Clin. Nutr. 1993, 58 (Suppl 5), 724S-732S.
19. Zubiria, M.G., Alzamendi, A., Moreno, G., Rey, M.A., Spinedi, E., Giovambattista, A. Long-Term Fructose Intake Increases Adipogenic Potential: Evidence of Direct Effects of Fructose on Adipocyte Precursor Cells. Nutrients 2016, 8, 198.
20. Masuzaki, H., Paterson, J., Shinyama, H., Morton, N.M., Mullins, J.J., Seckl, J.R., Flier, J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294, 2166-2170.
21. Tomlinson, J.W., Finney, J., Gay, C., Hughes, B.A., Hughes, S.V., Stewart, P.M. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes 2008, 57, 2652-2660.
22. Morton, N.M. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Mol. Cell Endocrinol. 2010, 316, 154-164.
23. London, E., Castonguay, T.W. High fructose diets increase 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral adipose in rats within 24-h exposure. Obesity 2011, 19, 925-932.
24. McCormick, K.L., Wang, X., Mick, G.J. Modification of microsomal 11beta-HSD1 activity by cytosolic compounds: Glutathione and hexose phosphoesters. J. Steroid. Biochem. Mol. Biol. 2008, 111, 18-23.
25. Senesi, S., Legeza, B., Balazs, Z., Csala, M., Marcolongo, P., Kereszturi, E., Szelenyi, P., Egger, C., Fulceri, R., Mandl, J., et al. Contribution of fructose-6-phosphate to glucocorticoid activation in the endoplasmic reticulum: Possible implication in the metabolic syndrome. Endocrinology 2010, 151, 4830-4839.
26. Staab, C.A., Maser, E. 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J. Steroid Biochem. Mol. Biol. 2010, 119, 56-72.
27. Lee, M.J., Pramyothin, P., Karastergiou, K., Fried, S.K. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity. Biochim. Biophys. Acta 2014, 1842, 473-481.
28. Banhegyi, G., Benedetti, A., Fulceri, R., Senesi, S. Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. J. Biol. Chem. 2004, 279, 27017-27021.
29. Atanasov, A.G., Nashev, L.G., Schweizer, R.A., Frick, C., Odermatt, A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett. 2004, 571, 129-133.
30. Odermatt, A., Arnold, P., Stauffer, A., Frey, B.M., Frey, F.J. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J. Biol. Chem. 1999, 274, 28762-28770.
31. Ozols, J. Lumenal orientation and post-translational modifications of the liver microsomal 11 beta-hydroxysteroid dehydrogenase. J. Biol. Chem. 1995, 270, 2305-2312.
32. Odermatt, A., Kratschmar, D.V. Tissue-specific modulation of mineralocorticoid receptor function by 11beta-hydroxysteroid dehydrogenases: An overview. Mol. Cell Endocrinol. 2012, 350, 168-186.
33. Tomlinson, J.W., Walker, E.A., Bujalska, I.J., Draper, N., Lavery, G.G., Cooper, M.S., Hewison, M., Stewart, P.M. 11beta-hydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response. Endocr. Rev. 2004, 25, 831-866.
34. Seckl, J.R. 11beta-hydroxysteroid dehydrogenases: Changing glucocorticoid action. Curr. Opin. Pharmacol. 2004, 4, 597-602.
35. Legeza, B., Balazs, Z., Odermatt, A. Fructose promotes the differentiation of 3T3-L1 adipocytes and accelerates lipid metabolism. FEBS Lett. 2014, 588, 490-496.
36. Welsh, J.A., Sharma, A., Abramson, J.L., Vaccarino, V., Gillespie, C., Vos, M.B. Caloric sweetener consumption and dyslipidemia among US adults. JAMA 2010, 303, 1490-1497.
37. Basu, S., Yoffe, P., Hills, N., Lustig, R.H. The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data. PLoS ONE 2013, 8, e57873.
38. Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J.L., Diehl, A.M., Johnson, R.J., Abdelmalek, M.F. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 2008, 48, 993-999.
39. Elliott, S.S., Keim, N.L., Stern, J.S., Teff, K., Havel, P.J. Fructose, weight gain, and the insulin resistance syndrome. Am. J. Clin. Nutr. 2002, 76, 911-922.
40. Johnson, R.J., Segal, M.S., Sautin, Y., Nakagawa, T., Feig, D.I., Kang, D.H., Gersch, M.S., Benner, S., Sanchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899-906.
41. Dennison, B.A., Rockwell, H.L., Baker, S.L. Excess fruit juice consumption by preschool-aged children is associated with short stature and obesity. Pediatrics 1997, 99, 15-22.
42. Ludwig, D.S., Peterson, K.E., Gortmaker, S.L. Relation between consumption of sugar-sweetened drinks and childhood obesity: A prospective, observational analysis. Lancet 2001, 357, 505-508.
43. Schulze, M.B., Manson, J.E., Ludwig, D.S., Colditz, G.A., Stampfer, M.J., Willett, W.C., Hu, F.B. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004, 292, 927-934.
44. Ma, J., McKeown, N.M., Hwang, S.J., Hoffmann, U., Jacques, P.F.C.S. Fox, Sugar-Sweetened Beverage Consumption Is Associated With Change of Visceral Adipose Tissue Over 6 Years of Follow-Up. Circulation 2016, 133, 370-377.
45. Stanhope, K.L., Schwarz, J.M., Keim, N.L., Griffen, S.C., Bremer, A.A., Graham, J.L., Hatcher, B., Cox, C.L., Dyachenko, A., Zhang, W., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119, 1322-1334.
46. Ha, V., Jayalath, V.H., Cozma, A.I., Mirrahimi, A., de Souza, R.J., Sievenpiper, J.L. Fructose-containing sugars, blood pressure, and cardiometabolic risk: A critical review. Curr. Hypertens. Rep. 2013, 15, 281-297.
47. Sievenpiper, J.L., de Souza, R.J., Mirrahimi, A., Yu, M.E., Carleton, A.J., Beyene, J., Chiavaroli, L., di Buono, M., Jenkins, A.L., Leiter, L.A., et al. Effect of fructose on body weight in controlled feeding trials: A systematic review and meta-analysis. Ann Intern. Med. 2012, 156, 291-304.
48. Wang, D.D., Sievenpiper, J.L., de Souza, R.J., Chiavaroli, L., Ha, V., Cozma, A.I., Mirrahimi, A., Yu, M.E., Carleton, A.J., di Buono, M., et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J. Nutr. 2012, 142, 916-923.
49. Matsuzaka, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Tomita, S., Sekiya, M., et al. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 2004, 53, 560-569.
50. Bantle, J.P., Raatz, S.K., Thomas, W., Georgopoulos, A. Effects of dietary fructose on plasma lipids in healthy subjects. Am. J. Clin. Nutr. 2000, 72, 1128-1134.
51. Bantle, J.P., Swanson, J.E., Thomas, W., Laine, D.C. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 1992, 15, 1468-1476.
52. Shapiro, A., Mu, W., Roncal, C., Cheng, K.Y., Johnson, R.J., Scarpace, P.J. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295, R1370-R1375.
53. Le, K.A., Faeh, D., Stettler, R., Ith, M., Kreis, R., Vermathen, P., Boesch, C., Ravussin, E., Tappy, L. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 2006, 84, 1374-1379.
54. Le, K.A., Ith, M., Kreis, R., Faeh, D., Bortolotti, M., Tran, C., Boesch, C., Tappy, L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 2009, 89, 1760-1765.
55. Nakagawa, T., Hu, H., Zharikov, S., Tuttle, K.R., Short, R.A., Glushakova, O., Ouyang, X., Feig, D.I., Block, E.R., Herrera-Acosta, J., et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal. Physiol. 2006, 290, F625-F631.
56. Bremer, A.A., Stanhope, K.L., Graham, J.L., Cummings, B.P., Wang, W., Saville, B.R., Havel, P.J. Fructose-fed rhesus monkeys: A nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes. Clin. Transl. Sci. 2011, 4, 243-252.
57. Johnson, R.J., Perez-Pozo, S.E., Sautin, Y.Y., Manitius, J., Sanchez-Lozada, L.G., Feig, D.I., Shafiu, M., Segal, M., Glassock, R.J., Shimada, M., et al. Hypothesis: Could excessive fructose intake and uric acid cause type 2 diabetes? Endocr. Rev. 2009, 30, 96-116.
58. Mayes, P.A. Intermediary metabolism of fructose. Am. J. Clin. Nutr. 1993, 58, 754S-765S.
59. Douard, V., Ferraris, R.P. Regulation of the fructose transporter GLUT5 in health and disease. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E227-E237.
60. Hajduch, E., Darakhshan, F., Hundal, H.S. Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes. Diabetologia 1998, 41, 821-828.
61. Du, L., Heaney, A.P. Regulation of adipose differentiation by fructose and GluT5. Mol. Endocrinol. 2012, 26, 1773-1782.
62. Froesch, E.R. Fructose metabolism in adipose tissue. Acta Med. Scand. Suppl. 1972, 542, 37-46.
63. Varma, V., Boros, L.G., Nolen, G.T., Chang, C.W., Wabitsch, M., Beger, R.D., Kaput, J. Metabolic fate of fructose in human adipocytes: A targeted 13C tracer fate association study. Metabolomics 2015, 11, 529-544.
64. Varma, V., Boros, L.G., Nolen, G.T., Chang, C.W., Wabitsch, M., Beger, R.D., Kaput, J. Fructose Alters Intermediary Metabolism of Glucose in Human Adipocytes and Diverts Glucose to Serine Oxidation in the One-Carbon Cycle Energy Producing Pathway. Metabolites 2015, 5, 364-385.
65. Tedeschi, P.M., Markert, E.K., Gounder, M., Lin, H., Dvorzhinski, D., Dolfi, S.C., Chan, L.L., Qiu, J., DiPaola, R.S., Hirshfield, K.M., et al. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis. 2013, 4, e877.
66. Trommelen, J., Fuchs, C.J., Beelen, M., Lenaerts, K., Jeukendrup, A.E., Cermak, N.M., van Loon, L.J. Fructose and Sucrose Intake Increase Exogenous Carbohydrate Oxidation during Exercise. Nutrients 2017, 9.
67. Smith, J.W., Zachwieja, J.J., Peronnet, F., Passe, D.H., Massicotte, D., Lavoie, C., Pascoe, D.D. Fuel selection and cycling endurance performance with ingestion of [13C]glucose: Evidence for a carbohydrate dose response. J. Appl. Physiol. 2010, 108, 1520-1529.
68. Baur, D.A., Schroer, A.B., Luden, N.D., Womack, C.J., Smyth, S.A., Saunders, M.J. Glucose-fructose enhances performance versus isocaloric, but not moderate, glucose. Med. Sci. Sports. Exerc. 2014, 46, 1778-1786.
69. Rowlands, D.S., Swift, M., Ros, M., Green, J.G. Composite versus single transportable carbohydrate solution enhances race and laboratory cycling performance. Appl. Physiol. Nutr. Metab. 2012, 37, 425-436.
70. Bally, L., Kempf, P., Zueger, T., Speck, C., Pasi, N., Ciller, C., Feller, K., Loher, H., Rosset, R., Wilhelm, M., et al. Metabolic Effects of Glucose-Fructose Co-Ingestion Compared to Glucose Alone during Exercise in Type 1 Diabetes. Nutrients 2017, 9.
71. Lecoultre, V., Benoit, R., Carrel, G., Schutz, Y., Millet, G.P., Tappy, L., Schneiter, P. Fructose and glucose co-ingestion during prolonged exercise increases lactate and glucose fluxes and oxidation compared with an equimolar intake of glucose. Am. J. Clin. Nutr. 2010, 92, 1071-1079.
72. Sahebjami, H., Scalettar, R. Effects of fructose infusion on lactate and uric acid metabolism. Lancet 1971, 1, 366-369.
73. Gregoire, F.M., Smas, C.M., Sul, H.S. Understanding adipocyte differentiation. Physiol. Rev. 1998, 78, 783-809.
74. Lee, M.J., Fried, S.K. The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role in adipogenesis and adipokine production in human adipocytes. Int. J. Obes. (Lond.) 2014, 38, 1228-1233.
75. Rosen, E.D., Spiegelman, B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 2000, 16, 145-171.
76. Wang, Y., Zhao, L., Smas, C., Sul, H.S. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol. Cell Biol. 2010, 30, 3480-3492.
77. De Sa, P.M., Richard, A.J., Hang, H., Stephens, J.M. Transcriptional Regulation of Adipogenesis. Compr. Physiol. 2017, 7, 635-674.
78. Poulos, S.P., Dodson, M.V., Culver, M.F., Hausman, G.J. The increasingly complex regulation of adipocyte differentiation. Exp. Biol. Med. (Maywood) 2016, 241, 449-456.
79. Mastrocola, R., Nigro, D., Chiazza, F., Medana, C., Bello, F.D., Boccuzzi, G., Collino, M., Aragno, M. Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice. Free Radic. Biol. Med. 2016, 91, 224-235.
80. Robubi, A., Huber, K.R., Krugluger, W. Extra fructose in the growth medium fuels lipogenesis of adipocytes. J. Obes. 2014, 2014, 647034.
81. Balakumar, M., Raji, L., Prabhu, D., Sathishkumar, C., Prabu, P., Mohan, V., Balasubramanyam, M. High-fructose diet is as detrimental as high-fat diet in the induction of insulin resistance and diabetes mediated by hepatic/pancreatic endoplasmic reticulum (ER) stress. Mol. Cell Biochem. 2016, 423, 93-104.
82. Samuel, V.T., Petersen, K.F., Shulman, G.I. Lipid-induced insulin resistance: Unravelling the mechanism. Lancet 2010, 375, 2267-2277.
83. Ye, J., DeBose-Boyd, R.A. Regulation of cholesterol and fatty acid synthesis. Cold Spring Harb. Perspect. Biol. 2011, 3.
84. Petrie, J.L., Patman, G.L., Sinha, I., Alexander, T.D., Reeves, H.L., Agius, L. The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. Am. J. Physiol. Endocrinol. Metab. 2013, 305, E1255-E1265.
85. Perheentupa, J., Raivio, K. Fructose-induced hyperuricaemia. Lancet 1967, 2, 528-531.
86. Fiaschi, E., Baggio, B., Favaro, S., Antonello, A., Camerin, E., Todesco, S., Borsatti, A. Fructose-induced hyperuricemia in essential hypertension. Metabolism 1977, 26, 1219-1223.
87. Israel, K.D., Michaelis, O.E.T., Reiser, S., Keeney, M. Serum uric acid, inorganic phosphorus, and glutamic-oxalacetic transaminase and blood pressure in carbohydrate-sensitive adults consuming three different levels of sucrose. Ann. Nutr. Metab. 1983, 27, 425-435.
88. Reiser, S., Powell, A.S., Scholfield, D.J., Panda, P., Ellwood, K.C., Canary, J.J. Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch. Am. J. Clin. Nutr. 1989, 49, 832-839.
89. Odermatt, A. TheWestern-style diet: A major risk factor for impaired kidney function and chronic kidney disease. Am. J. Physiol. Renal. Physiol. 2011, 301, F919-F931.
90. Bos, M.J., Koudstaal, P.J., Hofman, A., Witteman, J.C., Breteler, M.M. Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke 2006, 37, 1503-1507.
91. Jin, M., Yang, F., Yang, I., Yin, Y., Luo, J.J., Wang, H., Yang, X.F. Uric acid, hyperuricemia and vascular diseases. Front. Biosci. 2012, 17, 656-669.
92. Sanchez-Lozada, L.G., Tapia, E., Bautista-Garcia, P., Soto, V., Avila-Casado, C., Vega-Campos, I.P., Nakagawa, T., Zhao, L., Franco, M., Johnson, R.J. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am. J. Physiol. Renal. Physiol. 2008, 294, F710-F718.
93. Sautin, Y.Y., Nakagawa, T., Zharikov, S., Johnson, R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am. J. Physiol. Cell Physiol. 2007, 293, C584-C596.
94. Cheung, K.J., Tzameli, I., Pissios, P., Rovira, I., Gavrilova, O., Ohtsubo, T., Chen, Z., Finkel, T., Flier, J.S., Friedman, J.M. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab. 2007, 5, 115-128.
95. Stavric, B., Johnson, W.J., Clayman, S., Gadd, R.E., Chartrand, A. Effect of fructose administration on serum urate levels in the uricase inhibited rat. Experientia 1976, 32, 373-374.
96. Watanabe, S., Kang, D.H., Feng, L., Nakagawa, T., Kanellis, J., Lan, H., Mazzali, M., Johnson, R.J. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002, 40, 355-360.
97. Vasdev, S., Gill, V., Parai, S., Longerich, L., Gadag, V. Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats. Mol. Cell Biochem. 2002, 241, 107-114.
98. Kanellis, J., Watanabe, S., Li, J.H., Kang, D.H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H.Y., Feng, L., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41, 1287-1293.
99. Gregor, M.F., Hotamisligil, G.S. Thematic review series: Adipocyte Biology. Adipocyte stress: The endoplasmic reticulum and metabolic disease. J. Lipid. Res. 2007, 48, 1905-1914.
100. Rosen, E.D., MacDougald, O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7, 885-896.
101. Marek, G., Pannu, V., Shanmugham, P., Pancione, B., Mascia, D., Crosson, S., Ishimoto, T., Sautin, Y.Y. Adiponectin resistance and proinflammatory changes in the visceral adipose tissue induced by fructose consumption via ketohexokinase-dependent pathway. Diabetes 2015, 64, 508-518.
102. Wang, Z.V., Schraw, T.D., Kim, J.Y., Khan, T., Rajala, M.W., Follenzi, A., Scherer, P.E. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol. Cell Biol. 2007, 27, 3716-3731.
103. Diggle, C.P., Shires, M., Leitch, D., Brooke, D., Carr, I.M., Markham, A.F., Hayward, B.E., Asipu, A., Bonthron, D.T. Ketohexokinase: Expression and localization of the principal fructose-metabolizing enzyme. J. Histochem. Cytochem. 2009, 57, 763-774.
104. Suzuki, T., Gao, J., Ishigaki, Y., Kondo, K., Sawada, S., Izumi, T., Uno, K., Kaneko, K., Tsukita, S., Takahashi, K., et al. ER Stress Protein CHOP Mediates Insulin Resistance by Modulating Adipose Tissue Macrophage Polarity. Cell Rep. 2017, 18, 2045-2057.
105. Hoppmann, J., Perwitz, N., Meier, B., Fasshauer, M., Hadaschik, D., Lehnert, H., Klein, J. The balance between gluco—And mineralo-corticoid action critically determines inflammatory adipocyte responses. J. Endocrinol. 2010, 204, 153-164.
106. Zhang, T.Y., Daynes, R.A. Macrophages from 11beta-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-beta-mediated up-regulation of SHIP1 expression. J. Immunol. 2007, 179, 6325-6335.
107. Wang, L., Liu, J., Zhang, A.S., Cheng, P., Zhang, X., Lv, S., Wu, L., Yu, J., Di, W.J., Zha, J.M., et al. BVT.2733, a Selective 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice. PLoS ONE 2012, 7.
108. Park, S.B., Park, J.S., Jung, W.H., Kim, H.Y., Kwak, H.J., Ahn, J.H., Choi, K.J., Na, Y.J., Choi, S., Rhee, S.D., et al. Anti-inflammatory effect of a selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor via the stimulation of heme oxygenase-1 in LPS-activated mice and J774.1 murine macrophages. J. Pharmacol. Sci. 2016, 131, 241-250.
109. Luo, M.J.J., Thieringer, R., Springer, M.S., Wright, S.D., Hermanowski-Vosatka, A., Plump, A., Balkovec, J.M., Cheng, K., Ding, G.J., Kawka, D.W., et al. 11 beta-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature. Physiol. Genom. 2013, 45, 47-57.
110. Chantong, B., Kratschmar, D.V., Nashev, L.G., Balazs, Z., Odermatt, A. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J. Neuroinflamm. 2012, 9, 260.
111. Hirata, A., Maeda, N., Nakatsuji, H., Hiuge-Shimizu, A., Okada, T., Funahashi, T., Shimomura, I. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction. Biochem. Biophys. Res. Commun. 2012, 419, 182-187.
112. Farina, J.P., Garcia, M.E., Alzamendi, A., Giovambattista, A., Marra, C.A., Spinedi, E., Gagliardino, J.J. Antioxidant treatment prevents the development of fructose-induced abdominal adipose tissue dysfunction. Clin. Sci. 2013, 125, 87-97.
113. Lavine, J.E., Schwimmer, J.B., van Natta, M.L., Molleston, J.P., Murray, K.F., Rosenthal, P., Abrams, S.H., Scheimann, A.O., Sanyal, A.J., Chalasani, N., et al. Nonalcoholic Steatohepatitis Clinical Research, Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial. JAMA 2011, 305, 1659-1668.
114. Sanyal, A.J., Chalasani, N., Kowdley, K.V., McCullough, A., Diehl, A.M., Bass, N.M., Neuschwander-Tetri, B.A., Lavine, J.E., Tonascia, J., Unalp, A., et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 2010, 362, 1675-1685.
115. Bujalska, I.J., Kumar, S., Stewart, P.M. Does central obesity reflect ”Cushing’s disease of the omentum”? Lancet 1997, 349, 1210-1213.
116. Stewart, P.M. Tissue-specific Cushing’s syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur. J. Endocrinol. 2003, 149, 163-168.
117. Corbalan-Tutau, D., Madrid, J.A., Nicolas, F., Garaulet, M. Daily profile in two circadian markers ”melatonin and cortisol” and associations with metabolic syndrome components. Physiol. Behav. 2014, 123, 231-235.
118. Cardoso, E.M., Arregger, A.L., Monardes, G., Contreras, L.N. An accurate, non-invasive approach to diagnose Cushing’s syndrome in at-risk populations. Steroids 2013, 78, 476-482.
119. Reinehr, T., Kulle, A., Wolters, B., Knop, C., Lass, N., Welzel, M., Holterhus, P.M. Relationships between 24-hour urinary free cortisol concentrations and metabolic syndrome in obese children. J. Clin. Endocrinol. Metab. 2014, 99, 2391-2399.
120. Livingstone, D.E., Jones, G.C., Smith, K., Jamieson, P.M., Andrew, R., Kenyon, C.J., Walker, B.R. Understanding the role of glucocorticoids in obesity: Tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000, 141, 560-563.
121. Wake, D.J., Strand, M., Rask, E., Westerbacka, J., Livingstone, D.E., Soderberg, S., Andrew, R., Yki-Jarvinen, H., Olsson, T., Walker, B.R. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin. Endocrinol. (Oxf.) 2007, 66, 440-446.
122. Rask, E., Walker, B.R., Soderberg, S., Livingstone, D.E., Eliasson, M., Johnson, O., Andrew, R., Olsson, T. Tissue-specific changes in peripheral cortisol metabolism in obese women: Increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab. 2002, 87, 3330-3336.
123. Rask, E., Olsson, T., Soderberg, S., Andrew, R., Livingstone, D.E., Johnson, O., Walker, B.R. Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 2001, 86, 1418-1421.
124. Stewart, P.M., Boulton, A., Kumar, S., Clark, P.M., Shackleton, C.H. Cortisol metabolism in human obesity: Impaired cortisone!cortisol conversion in subjects with central adiposity. J. Clin. Endocrinol. Metab. 1999, 84, 1022-1027.
125. Westerbacka, J., Yki-Jarvinen, H., Vehkavaara, S., Hakkinen, A.M., Andrew, R., Wake, D.J., Seckl, J.R., Walker, B.R. Body fat distribution and cortisol metabolism in healthy men: Enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J. Clin. Endocrinol. Metab. 2003, 88, 4924-4931.
126. Kotelevtsev, Y., Holmes, M.C., Burchell, A., Houston, P.M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C.R., Seckl, J.R., et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. USA 1997, 94, 14924-14929.
127. Marcolongo, P., Senesi, S., Giunti, R., Csala, M., Fulceri, R., Banhegyi, G., Benedetti, A. Expression of hexose-6-phosphate dehydrogenase in rat tissues. J. Steroid. Biochem. Mol. Biol. 2011, 126, 57-64.
128. Marcolongo, P., Senesi, S., Gava, B., Fulceri, R., Sorrentino, V., Margittai, E., Lizak, B., Csala, M., Banhegyi, G., Benedetti, A. Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum. Biochem. Pharmacol. 2008, 76, 382-390.
129. Hauner, H., Entenmann, G., Wabitsch, M., Gaillard, D., Ailhaud, G., Negrel, R., Pfeiffer, E.F. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Investig. 1989, 84, 1663-1670.
130. Hauner, H., Schmid, P., Pfeiffer, E.F. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J. Clin. Endocrinol. Metab. 1987, 64, 832-835.
131. Tomlinson, J.W., Stewart, P.M. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue. Horm. Metab. Res. 2002, 34, 746-751.
132. Bujalska, I.J., Kumar, S., Hewison, M., Stewart, P.M. Differentiation of adipose stromal cells: The roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 1999, 140, 3188-3196.
133. Liu, Y., Park, F., Pietrusz, J.L., Jia, G., Singh, R.J., Netzel, B.C., Liang, M. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis. Physiol. Genom. 2008, 32, 343-351.
134. Mandl, J., Meszaros, T., Banhegyi, G., Hunyady, L., Csala, M. Endoplasmic reticulum: Nutrient sensor in physiology and pathology. Trend Endocrinol. Metab. TEM 2009, 20, 194-201.
135. Dzyakanchuk, A.A., Balazs, Z., Nashev, L.G., Amrein, K.E., Odermatt, A. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose. Mol. Cell Endocrinol. 2009, 301, 137-141.
136. Gumy, C., Thurnbichler, C., Aubry, E.M., Balazs, Z., Pfisterer, P., Baumgartner, L., Stuppner, H., Odermatt, A., Rollinger, J.M. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines. Fitoterapia 2009, 80, 200-205.
137. Froesch, E.R., Ginsberg, J.L. Fructose metabolism of adipose tissue. I. Comparison of fructose and glucose metabolism in epididymal adipose tissue of normal rats. J. Biol. Chem. 1962, 237, 3317-3324.
138. Apostolova, G., Schweizer, R.A., Balazs, Z., Kostadinova, R.M., Odermatt, A. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E957-E964.
139. Balazs, Z., Schweizer, R.A., Frey, F.J., Rohner-Jeanrenaud, F., Odermatt, A. DHEA induces 11-HSD2 by acting on CCAAT/enhancer-binding proteins. J. Am. Soc. Nephrol. 2008, 19, 92-101.
140. Prince, P.D., Santander, Y., Gerez, E.M., Hocht, C., Polizio, A.H., Mayer, M.A., Taira, C.A., Fraga, C.G., Galleano, M., Carranza, A. Fructose increases corticosterone production in association with NADPH metabolism alterations in rat epididymal white adipose tissue. J. Nutrit. Biochem. 2017.
141. Kovacevic, S., Nestorov, J., Matic, G., Elakovic, I. Fructose and stress induce opposite effects on lipid metabolism in the visceral adipose tissue of adult female rats through glucocorticoid action. Europ. J. Nutr. 2016.
142. Bursac, B.N., Djordjevic, A.D., Vasiljevic, A.D., Milutinovic, D.D., Velickovic, N.A., Nestorovic, N.M., Matic, G.M. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J. Nutr. Biochem. 2013, 24, 1166-1172.
143. Bursac, B.N., Vasiljevic, A.D., Nestorovic, N.M., Velickovic, N.A., Milutinovic, D.D.V., Matic, G.M., Djordjevic, A.D. High-fructose diet leads to visceral adiposity and hypothalamic leptin resistance in male rats—Do glucocorticoids play a role? J. Nutr. Biochem. 2014, 25, 446-455.
144. Priyadarshini, E., Anuradha, C.V. Glucocorticoid Antagonism Reduces Insulin Resistance and Associated Lipid Abnormalities in High-Fructose-Fed Mice. Can. J. Diabet. 2017, 41, 41-51.
145. Larner, D.P., Morgan, S.A., Gathercole, L.L., Doig, C.L., Guest, P., Weston, C., Hazeldine, J., Tomlinson, J.W., Stewart, P.M., Lavery, G.G. Male 11beta-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease. Endocrinology 2016, 157, 3493-3504.
146. Hellerstein, M.K. De novo lipogenesis in humans: Metabolic and regulatory aspects. Eur. J. Clin. Nutr. 1999, 53, S53-S65.
147. Baxter, J.D., Forsham, P.H. Tissue effects of glucocorticoids. Am. J. Med. 1972, 53, 573-589.
148. Dolinsky, V.W., Douglas, D.N., Lehner, R., Vance, D.E. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. Biochem. J. 2004, 378, 967-974.
149. Morgan, S.A., McCabe, E.L., Gathercole, L.L., Hassan-Smith, Z.K., Larner, D.P., Bujalska, I.J., Stewart, P.M., Tomlinson, J.W., Lavery, G.G. 11beta-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc. Natl. Acad Sci. USA 2014, 111, E2482-E2491.